Использованная литература

181. Girdaukas E., Kempfert J., Kuntze T. et al. Thromboelastometrically guided transfusion protocol during aortic surgery with circulatory arrest: a prospective, randomized trial // J. Thorac. Cardiovasc. Surg. 2010. Vol. 140. P. 1117–1120.

182. Golberg J. Paugh T., Dickinson T. et al. Greater volume of acute normovolemic hemodilution may aid in reducing blood transfusion in cardiac surgery // Ann. Thorac. Surg. 2015. Vol. 100. P. 1581–1587.

183. Golinger K., Dirkmann D., Hanke A. et al. First-line Therapy with Coagulation Factor Concentrates Combined with Poin-of-Care Coagulation Testing Is Associated with Decreased Allogeneic Blood Transfusion in Cardiovascular Surgery // Anesthesiology. 2011. V. 115. P. 1179–1191.

184. Goodnough L.T., Shander A. Patient blood management // Anesthesiology. 2012. Vol. 116. N. 6. P. 1367–1376.

185. Gran M., Resar M., Frank S. The efficacy and utility of acute normovolemic hemodilution // Anesth. Analg. 2015. Vol. 121. P. 1412–1414.

186. Guidelines for the use of fresh-frozen plasma, cryoprecipitate and cryosupernatant // The British Siciety for Haemotology. 2004. Vol. 126. P. 11–28.

187. Guide to the preparation, use and quality assurance of blood components. Recommendation. Council of Europe, 2006. 268 p.

188. Hallett J.W., Popovsky M., Ilstryp D. Minimizing blood transfusions during abdominal aortic surgery recent advances in rapid autotransfusion // J. Vasc. Surg. 1987. Vol. 5. P. 601.

189. Hanke J., Radevold L., Joch C., Gorlinger K. Efficacy and long-term safety of a protrombin complex concentrate // Tromb. Haemost. 2009. Vol. 7. Suppl. 2. P. 863.

190. Hanke A., Pichmair M., Haverich A. et al. Thrombelastomety based goal-directed management reduces blood transfusion in acute type A aortic dissection // Transfus. Med. Hemother. 2012. N. 39. P. 121–128.

191. Karkouti K., Wijeysundera D.N., Yau T.M. et al. The independent assoсiation of massive blood loss with mortality in cardiac surgery // Transfusion. 2004. N. 44. P. 1453–1462.

192. Kochamba G., Pfeffer C., Sintk C. Intraoperative autotransfusion reduces blood loss after cardiopulmonary bypass // Ann. Thorac. Surgg. 1996. Vol. 61. P. 900–903.

193. Kozek S., Sorensen B., Hess J. et al. Clinical effectiveness of fresh frozen plasma compared with fibrinogen concentration // Crit. Care. 2011. N. 15. P. R 239.

194. Kuhn D.F., Braun H., Taborski B., Hempelmann G. Novel Therapeutic Options due to Autologous Blood Components Exemplified by Autologous Platelet Gel // Transfusion Medicine and Hemoterapy. 2006. Vol. 33. P. 307–313.

195. McCullough J. Autologous Blood Donation and Transfusion // Transfusion Medicine. USA, Philadelphia, 2005. Р. 111–130.

196. Morrison G., Chalmers R., Solomon C. et al. Fibrinogen concentrate therapy guided by thromboelastometry as an alternative to fresh frozen plasma in major vascular surgery // J. Cardiothorac. Vasc. Anesth. 2012. N. 26. P. 654–659.

197. Murphy G., Reeves R., Rogers C. et al. Increased mortality, morbidity and cost after red blood cell transfusions in cardiac surgery //Circulation. 2007. Vol. 116. P. 2544–2552.

198. Naka T., Jones D., Baldwin G. et al. Myoglobin clearance by Super high-flux hemofiltration in a case of severe rhabdomyolysis: a care report // Crit. Care. 2005. Vol. 9. N. 2. P. R90–R95. DOI: 10.1186/cc30-34.

199. Nalla B., Freedman J., Hare G. Update on blood conservation for cardiac surgery // J. Cardiothorac.Vasc. Anesth. 2012. Vol. 26. N. 1. P. 117–133.

200. Ng H.J. Two cases of trombosis associated with use of recоmbinant factor VIIa in Singapore // 7 Novo Nordisk symposium on hemostasis management 2003. Abstracts. С. 26.

201. Rahe-Meyer N., Pichlmaier M., Haverich A. Bleeding management with fibrinogen concentration targeting high-normal plasma fibrinogen // Br. J. Anesth. 2009. Vol. 102. P. 785–792.

202. Ranuci R.N., Subrananiam K., Marquer J. et al. Safety and efficacy of Tranexamic Acid compared with Aprotinin in thoracic aortic surgery with deep hypothermic circulatory arrest // J. Cardiothorac. Vasc. Anesth. 2010. Vol 24. P. 73–79.

203. Ranuci M. and EACTA Perioperative haemostasis and coagulation management in cardiac surgery // Eur. J. Anaesthesiol. 2007. Vol. 24. Suppl. 40. P. 1–13.

204. Robinson K., Savoia H., Street A. Trombotic complications in two patients receiving Novoseven // Haemophilia. 2000. N. 6. P. 343–346.

205. Roman M., Biancari F., Ahmed A. et al. Prothrombin Complex Concentrate in cardiac surgery //Ann. Thorac. Surg. 2019. Vol. 107. N. 4. P. 1275–1283.

206. Ruseckaite R., McQuilten Z.K., Oldroyd J.C. et al. Descriptive characteristics and in-hospital mortality of critically bleeding patients requiring massive transfusion: results from the Australian and New Zealand Massive Transfusion Registry // Vox. Sanguinis. 2017. Vol. 112. N. 3. P. 240–248.

207. Sabloizki A., Stenke T., Schrubert S. et al. Serum cytokine levels as predictors of fatal outcome of severe sepsis following cardiovascular surgery // 1-st International Congress «Sepsis and Multyorgan Dysfunction». 2003. P. 8.

208. Sauaia A., Moore F.A., Moore E.E., Lezotte D.C. Early risk factors for postinjury multiple organ failure // World J. Surg. 1996. Vol. 20. P. 392–400.

209. Schwartr J., Padmanabhan A., Aqui N., Balogun R.A. et al. Guidelines on the Use of Therapeutic Apheresis in Clinical practice Еvidenсе-Based Approach from the Writing Committee of the American Society for Apheresis: The Seventh Special Issue // J. Clin. Aph. 2016. V. 31. Issue 3 P. 149–338.

210. Shander A., Moskowitz D., Rijhmani T. The safety and efficacy of bloodless cardiac surgery // Semin. Cardiothorac. Vasc. Anesth. 2005. Vol. 9. P. 53–69.

211. Spiliotopoulos K., Preventza O., Green S.Y. et al. Open descending thoracic or thoracoabdominal aortic approaches for complications of endovascular aortic procedures: 19-year experience // J. Thorasis. Cardiovascular. Surg. 2017. N. 11. P. 8–23. DOI: 10.1016/j.jtcvs.2017.08.023.

212. Suchow B.D., Goodney P.P., Columbo J.A. et al. National trends in оpen surgical, endovascular, and branched-fenestrated endovascular aortic aneurysm repair in Medicare patients // J. Vasc. Surg. 2017. N. 24. P. 1–8.

213. Tanaka K., Bollige D., Vadlamudi R. et al: ROTEM- based coagulation management in cardiac surgery // J. Cardiothorac. Anesth. 2012. Vol. 26. P. 1083–1093.

214. Taniguchi T., Koido Y., Aibosti J. et al. Change in the ratio of IL-6 to IL-10 predicts a poor outcome with patients SIRS // Crit. Care Med. 1999. Vol. 27. P. 1262–1264.

215. Ternstrom L., Radutovich V., Karisson F. et al. Plasma activity of individual concentration factors, hemodilution and blood loss after cardiac surgery. A prospective observational study // Tromb. Res. 2010. Vol. 26 P. 128–133.

216. Therapeutic Plasmapheresis (XYI). Proceedings of the First International Conference for Apheresis // Jap. J. Apheresis. 1997. Vol. 16. N. 1.

217. The Society of Thoracic Surgeons Guideline Perioperative Blood Transfusion and Blood Conservation in Cardiac Surgery // Ann. Thorac. Surg. 2011. Vol. 91. P. 944–982.

218. Vamvakas E.C. Reasons for moving toward a patient centric paradigm of clinical transfusion medicine practice // Transfusion. 2013. Vol. 53. N. 4. P. 888–901.

219. Venkatesan P. NICE guideline on long COVID // Lancet Respir. Med. 2021. Vol. 9. N. 2. P. 129. DOI: 10.1016/S2213-2600(21)00031-X.

220. Vercamest L. Hemolysis in cаrdiac surgery patients undergoing cаrdiopulmonary bypass: A review in search of a treatment algorithm // J. Extra Corporeal. Techology. 2008. Vol. 40. N. 4. Р. 257–267.

221. Vincent J.L. Prevention and Therapy of Multiple organ failure // World J. Surg. 1996. Vol. 20. P. 465–470.

222. Vivacqua A., Coch C., Yousut A. et al. Morbidity of bleeding in cardiac surgery: it is blood transfusion, reoperation of bleeding or both // Ann. Thorac. Surg. 2011. Vol. 91. P. 1780–1790.

223. Volker Kretschmer. Preoperative Autologous Blood Donation- a’Confessor’s’Point of View // Transfus. Med. Hemother. 2006. Vol. 33. P. 330–335.

224. Wang J., Ma H., Zheng H. Blood loss after cardiopulmonary bypass. A meta-.analysis // The Nethelands J. Med. 2013. Vol. 71. P. 123–127.

225. Westaby S. Anti-fibrinolytic therapy in thoracic aortic surgery // Ann. Thorac. Surg. 1999. Vol. 67 P. 1983–1985.

226. Whitson B., Yudleston S., Savik K. et all. Risk of adverse outcomes associated with blood transfusion after cardiac surgery // J. Surg. Res. 2010. Vol. 158. P. 20–22.

227. Zhou X., Zhang C., Wang Y. et al. Preoperative acute normovolemic hemodilution for minimizing allogenic blood transfusion: a meta-analysis // Anesth. Analg. 2015. Vol. 121. P. 1443–1455.

228. Zisman E., Eden A., Shenderey A. et al. The effect of autologous blood transfusion on coagulation dysfunction after cardiopulmonary bypass // Eur. J. Anaesthesiolog. 2009. Vol. 26. P. 868–873

229. 2017 EACTS/EACTA Guidelines on patient blood management for adult cardiac surgery // Eur. J. Cardio-Thoracic. Surg. Vol. 2117. P. 1–33.